News
Anthropic's Claude Opus 4 and OpenAI's models recently displayed unsettling and deceptive behavior to avoid shutdowns. What's ...
Explore how Birla Opus is challenging industry leader Asian Paints in India’s paint market with aggressive strategies, deep ...
Mani Ratnam has joined the debate and his is also a commendable response as actresses are now opting to spend time with ...
BWE Senior Vice President Max Sauerman and Vice President Tyler Shebeck originated a $205M senior loan and a $15M mezzanine ...
Anthropic uses innovative methods like Constitutional AI to guide AI behavior toward ethical and reliable outcomes ...
Monday marks the final day of Texas' 89th Legislative session, five months marred by debate, disagreement and compromise.
In April, it was reported that an advanced artificial i (AI) model would reportedly resort to "extremely harmful actions" to ...
Opus Genetics shares were up 22% at $1.21, after the company said it saw positive topline results from a pivotal Phase 3 clinical trial evaluating phentolamine ophthalmic solution 0.75% for the ...
Opus Genetics releases topline results from LYNX-2 evaluating phentolamine ophthalmic solution 0.75%
The phase 3 trial observed the treatment of chronic night driving impairment in keratorefractive patients with reduced ...
Due to AI, founders will become so efficient building companies that they will no longer need to raise multiple rounds of ...
The AI start-up has been making rapid advances thanks largely to the coding abilities of its family of Claude chatbots.
The $20/month Claude 4 Opus failed to beat its free sibling, Claude 4 Sonnet, in head-to-head testing. Here's how Sonnet ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results